Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan

被引:5
|
作者
Asai, Nobuhiro [1 ,2 ]
Sakanashi, Daisuke [2 ]
Suematsu, Hiroyuki [2 ]
Kato, Hideo [2 ]
Watanabe, Hiroki [1 ,2 ]
Shiota, Arufumi [2 ]
Hagihara, Mao [2 ]
Koizumi, Yusuke [1 ,2 ]
Yamagishi, Yuka [1 ,2 ]
Mikamo, Hiroshige [1 ,2 ]
机构
[1] Aichi Med Univ Hosp, Dept Clin Infect Dis, Nagakute, Aichi, Japan
[2] Aichi Med Univ Hosp, Dept Infect Control & Prevent, Nagakute, Aichi, Japan
关键词
Acinetobacter; Pneumonia; Community-acquired pneumonia; Healthcare-associated pneumonia; ACQUIRED PNEUMONIA; GUIDELINES; MANAGEMENT; SEVERITY; ADULTS;
D O I
10.1016/j.jiac.2019.03.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To clarify the etiology, patients' characteristics and risk factors for community-onset AP (Acinetobacter species pneumonia), we conducted this case-control study. We reviewed all patients with community-onset AP at our institute from 2010 until 2018. We defined non-AP group as a control. The patients with non-Acinetobacter spp. pneumonia (non-AP) were randomly selected during the study period without clinical information based on medical records' list among patients with community-onset pneumonia. The age (+/- 2 years) and sex were matched to the patients with community-onset AP, and the ratio was AP: non-AP group = 1: 3. Patients' characteristics, clinical outcomes, pathogens isolated and drug susceptibility were evaluated by comparing AP and non-AP group. The mean age of community-onset AP group was 79 years. They were 8 males and 5 females. The 30-day and in-hospital mortality rates of community-onset AP were 23% (v.s. 3%, p = 0.049) and 31% (v.s. 5%, p = 0.029) respectively, which are higher than the control group. Heavy alcohol consumption (23% v.v. 0%, p = 0.023), higher Charlson Comorbidity index (3.2 v.s. 2.0, p = 0.046) and lobar pneumonia by chest radiology (50% v.s. 23%, p = 0.071) were seen more frequently in community-onset AP than in the control group. In conclusion, community-onset AP shows poor outcomes despite the appropriate antibiotic therapy. Heavy alcohol history might be a risk factor of AP. Patients with community-onset AP could have more comorbidity and poor general conditions than the control group. (c) 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights
引用
收藏
页码:639 / 642
页数:4
相关论文
共 50 条
  • [1] A case of community-onset Acinetobacter pneumonia in a healthy person
    Nishimizu, Shoko
    Shiota, Seiji
    Oshiumi, Taro
    Takakura, Takeshi
    Miyazaki, Eishi
    IDCASES, 2021, 24
  • [2] Observational study in a single institute in Japan: How many community-onset pneumonia patients would have Clostridioides difficile infections after treatment?
    Asai, Nobuhiro
    Sakanashi, Daisuke
    Suematsu, Hiroyuki
    Kato, Hideo
    Shiota, Arufumi
    Hagihara, Mao
    Koizumi, Yusuke
    Yamagishi, Yuka
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (10) : 1104 - 1106
  • [3] Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia
    Noguchi, Shingo
    Yatera, Kazuhiro
    Kato, Tatsuji
    Chojin, Yasuo
    Fujino, Yoshihisa
    Akata, Kentaro
    Kawanami, Toshinori
    Sakamoto, Noriho
    Mukae, Hiroshi
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 2087 - 2094
  • [4] Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study
    Vasco Barreto, J.
    Dias, Claudia Camila
    Cardoso, Teresa
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 96 : 66 - 73
  • [5] Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae
    Seok, Hyeri
    Kang, Cheol-In
    Huh, Kyungmin
    Cho, Sun Young
    Ha, Young Eun
    Chung, Doo Ryeon
    Peck, Kyong Ran
    MICROBIAL DRUG RESISTANCE, 2018, 24 (09) : 1412 - 1416
  • [6] Study of factors related to recurrence within 30 days after pneumonia treatment for community-onset pneumonia
    Takeda, Satoshi
    Nagata, Nobuhiko
    Ueda, Yusuke
    Ikeuchi, Nobumitsu
    Akagi, Takanori
    Harada, Taishi
    Miyazaki, Hiroyuki
    Ushijima, Shinichiro
    Aoyama, Takashi
    Yoshida, Yuji
    Yatsugi, Hiroshi
    Wada, Kenji
    Ishii, Hiroshi
    Fujita, Masaki
    Watanabe, Kentaro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (12) : 1683 - 1688
  • [7] Factors associated with readmission for community-onset pneumonia among older people: A retrospective study
    Goto, Akihiko
    Umeki, Kenji
    Hiramatsu, Kazufumi
    Kadota, Jun-ichi
    Komiya, Kosaku
    RESPIRATORY INVESTIGATION, 2024, 62 (05) : 739 - 743
  • [8] Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia
    Wooten, D. A.
    Winston, L. G.
    RESPIRATORY MEDICINE, 2013, 107 (08) : 1266 - 1270
  • [9] Risk factors for IgA nephropathy: A case-control study in Japan
    Wakai, K
    Kawamura, T
    Matsuo, S
    Hotta, N
    Ohno, Y
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) : 738 - 745
  • [10] The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan
    Asai, Nobuhiro
    Sakanashi, Daisuke
    Suematsu, Hiroyuki
    Kato, Hideo
    Hagihara, Mao
    Nishiyama, Naoya
    Koizumi, Yusuke
    Yamagishi, Yuka
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (07) : 505 - 509